查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1615378

胃肠道粪便检验市场：按产品、测试、应用和最终用途 - 2025-2030 年全球预测

GI Stool Testing Market by Product (Analyzers, Consumables), Test (Bacteria Test, Fecal Biomarkers Test, Occult Blood Test), Application, End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，胃肠道粪便检验市值为6.5169亿美元，预计到2024年将达到6.9183亿美元，复合年增长率为6.67%，到2030年将达到10.2426亿美元。

GI（胃肠道）粪便检验是胃肠道疾病（包括感染疾病、发炎性疾病和癌症筛检）诊断和管理的重要组成部分。胃肠道粪便检验的范围包括旨在检测粪便样本中的病原体、血液和其他异常情况的各种测试，提供非侵入性诊断选择。此测试对于疾病的早期发现和管理至关重要，有助于改善患者预后和最佳治疗策略。在应用方面，胃肠道粪便检验广泛应用于医院、诊断实验室和家庭检测场景等临床环境。最终用户主要是医疗保健提供者、患者和研究机构。市场洞察预测，由于胃肠道疾病盛行率不断上升、早期筛检意识不断增强、考虑到便利性和隐私性的家庭检测套组的采用等，预计将出现强劲的成长轨迹。分子诊断和多目标粪便 DNA 检测等检测方法的技术进步是主要的成长要素，为快速、准确的诊断提供了新的可能性。个人化医疗和远端医疗的进步实现了远距分析并增强了患者参与度，进一步增强了这个市场机会。儘管前景乐观，但先进测试成本上升、资源匮乏地区的准入有限以及监管障碍等挑战构成了重大障碍。为了克服这些障碍，市场相关人员应专注于创新，特别是在具有成本效益、快速且易于使用的测试解决方案方面，并在全球范围内扩大意识计划。透过人工智慧和机器学习提高测试灵敏度和特异性的研究和开发是一个利润丰厚的探索领域。了解数位健康整合和预防性医疗保健策略等趋势可以为您带来市场优势。当相关人员将其目标与新的成长轨迹和技术变革相结合时，了解市场的动态性质及其机会和挑战至关重要。

主要市场统计
基准年[2023] 65169万美元
预计年份 [2024] 69183万美元
预测年份 [2030] 1,024,260,000 美元
复合年增长率（%） 6.67%

市场动态：揭示快速发展的胃肠道粪便检验市场的关键市场洞察

供需的动态交互作用正在改变胃肠道粪便检验市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 世界各地胃肠道疾病和疾病的增加
    • 政府和基金会努力提高胃肠健康意识
  • 市场限制因素
    • 胃肠道粪便检验中与产品召回相关的问题
  • 市场机会
    • 胃肠道粪便检验的技术进步可开发更准确、侵入性更小的工具
    • 医疗卫生政策改革及支持措施
  • 市场挑战
    • 产品标准化和相容性挑战

波特五力：驾驭胃肠道粪便检验市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解胃肠道粪便检验市场的外部影响

外部宏观环境因素在塑造胃肠道粪便检验市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解胃肠道粪便检验市场的竞争状况

胃肠道粪便检验市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵GI粪便检验市场供应商绩效评估

FPNV定位矩阵是评估胃肠道粪便检验市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，绘製胃肠道粪便检验市场的成功之路

对于想要加强在全球市场的影响力的公司来说，对胃肠道粪便检验市场进行策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球胃肠道疾病的发生率正在增加
      • 政府和基金会努力意识提升
    • 抑制因素
      • 与胃肠道粪便检验产品召回相关的问题
    • 机会
      • 胃肠道粪便检验方法的技术进步可开发更准确、侵入性更小的工具
      • 医疗卫生政策改革及支持措施
    • 任务
      • 产品标准化和相容性挑战
  • 市场区隔分析
    • 产品：胃肠粪便分析仪因诊断速度快、准确度高而成为首选
    • 最终使用者：扩大胃肠道粪便检验在诊断中心的应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 胃肠道粪便检验市场：依产品

  • 分析仪
  • 消耗品

第七章 胃肠道粪便检验市场按测试

  • 细菌测试
  • 粪便生物标记检测
    • 转铁蛋白测定
    • 肿瘤M2-PK粪便检验
  • 潜血检查
    • 癒创木脂 FOB粪便检验
    • 免疫FOB凝集试验
    • 免疫 FOB ELISA 测试
    • 侧流免疫FOB测试
  • 卵子和寄生虫测试

第八章 胃肠道粪便检验市场：依应用分类

  • 癌症
  • 胃食道逆流症
  • 感染
  • 发炎性肠道疾病

第九章 胃肠道粪便检验市场：依最终用途分类

  • 诊断中心
  • 家庭护理设置
  • 医院/诊所

第十章 北美和南美胃肠道粪便检验市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太胃肠道粪便检验市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲胃肠道粪便检验市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • ColoSense，非侵入性大肠直肠癌检测的突破，获得 FDA核准
    • 对 ColoTest 的评估，这是一种用于早期检测胃肠道疾病的消费者友善家庭筛检工具
    • Geneoscopy 与 LabCorp 合作增加了创新大肠直肠癌检测的机会
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Cardinal Health
  • Cenogenics Corporation
  • CTK Biotech, Inc.
  • Danaher Corporation
  • Diagnostic Solutions Laboratory, LLC
  • DiaSorin SpA
  • Eiken Chemical Co., Ltd.
  • Emes Software, LLC
  • Epitope Diagnostics Inc.
  • Geisinger Medical Laboratories
  • Genova Diagnostics Inc.
  • Helena Laboratories Corporation
  • Hologic Inc.
  • Lauriston Laboratories Ltd
  • Meridian Bioscience Inc.
  • Pinnacle BioLabs
  • Polymedco, LLC
  • Quest Diagnostics
  • QuidelOrtho Corporation
  • ScheBo Biotech AG
  • Siemens Healthineers
Product Code: MRR-CB04E056547A

The GI Stool Testing Market was valued at USD 651.69 million in 2023, expected to reach USD 691.83 million in 2024, and is projected to grow at a CAGR of 6.67%, to USD 1,024.26 million by 2030.

GI (Gastrointestinal) stool testing is an essential component in diagnosing and managing gastrointestinal disorders, including infections, inflammatory diseases, and cancer screening. The scope of GI stool testing encompasses a range of tests designed to detect pathogens, blood, and other anomalies in stool samples, offering a non-invasive diagnostic option. This testing is crucial for early detection and management of diseases, contributing to better patient outcomes and optimal treatment strategies. Application-wise, GI stool testing has widespread use in clinical settings such as hospitals, diagnostics laboratories, and home-testing scenarios. End-users primarily include healthcare providers, patients, and research institutions. Market insights reveal a robust growth trajectory, driven by increasing prevalence of GI diseases, rising awareness about early screening, and the adoption of home-testing kits due to convenience and privacy. Technological advancements in testing methodologies, such as molecular diagnostics and multi-target stool DNA testing, are key growth influencers, presenting novel possibilities for rapid and accurate diagnosis. The evolving landscape of personalized medicine and telehealth further bolsters opportunities in this market, enabling remote analysis and enhanced patient engagement. Despite the positive outlook, challenges such as high costs of advanced testing, limited accessibility in low-resource regions, and regulatory hurdles pose significant roadblocks. Market players need to focus on innovation, especially in cost-effective, rapid, and user-friendly testing solutions, as well as expanding awareness programs worldwide to overcome these barriers. Research and development in enhancing sensitivity and specificity of tests through AI and machine learning present lucrative areas for exploration. Recognizing trends like digital health integration and preventive healthcare strategies can provide competitive market advantages. Understanding the dynamic nature of the market, with its mix of opportunities and challenges, is crucial for stakeholders to align their objectives with emerging growth trajectories and technological shifts.

KEY MARKET STATISTICS
Base Year [2023] USD 651.69 million
Estimated Year [2024] USD 691.83 million
Forecast Year [2030] USD 1,024.26 million
CAGR (%) 6.67%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving GI Stool Testing Market

The GI Stool Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of gastrointestinal disorders and diseases across the world
    • Efforts by governments and foundations to raise awareness for gastrointestinal health
  • Market Restraints
    • Issues associated with product recalls in GI stool testing
  • Market Opportunities
    • Technological advancements in GI stool testing methods to develop more accurate and less invasive tools
    • Reforms and supportive measures in healthcare policies
  • Market Challenges
    • Challenges with product standardization and compatibility

Porter's Five Forces: A Strategic Tool for Navigating the GI Stool Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the GI Stool Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the GI Stool Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the GI Stool Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the GI Stool Testing Market

A detailed market share analysis in the GI Stool Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the GI Stool Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the GI Stool Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the GI Stool Testing Market

A strategic analysis of the GI Stool Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the GI Stool Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMerieux SA, Cardinal Health, Cenogenics Corporation, CTK Biotech, Inc., Danaher Corporation, Diagnostic Solutions Laboratory, LLC, DiaSorin S.p.A., Eiken Chemical Co., Ltd., Emes Software, LLC, Epitope Diagnostics Inc., Geisinger Medical Laboratories, Genova Diagnostics Inc., Helena Laboratories Corporation, Hologic Inc., Lauriston Laboratories Ltd, Meridian Bioscience Inc., Pinnacle BioLabs, Polymedco, LLC, Quest Diagnostics, QuidelOrtho Corporation, ScheBo Biotech AG, and Siemens Healthineers.

Market Segmentation & Coverage

This research report categorizes the GI Stool Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Analyzers and Consumables.
  • Based on Test, market is studied across Bacteria Test, Fecal Biomarkers Test, Occult Blood Test, and Ova and Parasites Test. The Fecal Biomarkers Test is further studied across Transferrin Assays and Tumor M2-PK Stool Test. The Occult Blood Test is further studied across Guaiac FOB Stool Test, Immuno FOB Agglutination Test, Immuno FOB ELISA Test, and Lateral Flow Immuno FOB Test.
  • Based on Application, market is studied across Cancer, Gastroesophageal Reflux Disease, Infection, and Inflammatory Bowel Disease.
  • Based on End-use, market is studied across Diagnostic Centers, Homecare Settings, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of gastrointestinal disorders and diseases across the world
      • 5.1.1.2. Efforts by governments and foundations to raise awareness for gastrointestinal health
    • 5.1.2. Restraints
      • 5.1.2.1. Issues associated with product recalls in GI stool testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in GI stool testing methods to develop more accurate and less invasive tools
      • 5.1.3.2. Reforms and supportive measures in healthcare policies
    • 5.1.4. Challenges
      • 5.1.4.1. Challenges with product standardization and compatibility
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Preference towards GI stool analyzers due to their speed and accuracy in diagnostics
    • 5.2.2. End-Users: Expanding application of GI Stool Testing in diagnostic centers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. GI Stool Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Analyzers
  • 6.3. Consumables

7. GI Stool Testing Market, by Test

  • 7.1. Introduction
  • 7.2. Bacteria Test
  • 7.3. Fecal Biomarkers Test
    • 7.3.1. Transferrin Assays
    • 7.3.2. Tumor M2-PK Stool Test
  • 7.4. Occult Blood Test
    • 7.4.1. Guaiac FOB Stool Test
    • 7.4.2. Immuno FOB Agglutination Test
    • 7.4.3. Immuno FOB ELISA Test
    • 7.4.4. Lateral Flow Immuno FOB Test
  • 7.5. Ova and Parasites Test

8. GI Stool Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Cancer
  • 8.3. Gastroesophageal Reflux Disease
  • 8.4. Infection
  • 8.5. Inflammatory Bowel Disease

9. GI Stool Testing Market, by End-use

  • 9.1. Introduction
  • 9.2. Diagnostic Centers
  • 9.3. Homecare Settings
  • 9.4. Hospitals & Clinics

10. Americas GI Stool Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific GI Stool Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa GI Stool Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. FDA Approval of ColoSense, A Breakthrough in Noninvasive Colorectal Cancer Screening
    • 13.3.2. Evaluation of ColoTest, A Consumer-Friendly, At-Home Screening Tool for Early Detection of Gastrointestinal Conditions
    • 13.3.3. Geneoscopy and Labcorp Partnership Elevates Access to Innovative Colorectal Cancer Screening
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Bio-Rad Laboratories, Inc.
  • 3. bioMerieux SA
  • 4. Cardinal Health
  • 5. Cenogenics Corporation
  • 6. CTK Biotech, Inc.
  • 7. Danaher Corporation
  • 8. Diagnostic Solutions Laboratory, LLC
  • 9. DiaSorin S.p.A.
  • 10. Eiken Chemical Co., Ltd.
  • 11. Emes Software, LLC
  • 12. Epitope Diagnostics Inc.
  • 13. Geisinger Medical Laboratories
  • 14. Genova Diagnostics Inc.
  • 15. Helena Laboratories Corporation
  • 16. Hologic Inc.
  • 17. Lauriston Laboratories Ltd
  • 18. Meridian Bioscience Inc.
  • 19. Pinnacle BioLabs
  • 20. Polymedco, LLC
  • 21. Quest Diagnostics
  • 22. QuidelOrtho Corporation
  • 23. ScheBo Biotech AG
  • 24. Siemens Healthineers

LIST OF FIGURES

  • FIGURE 1. GI STOOL TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. GI STOOL TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GI STOOL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GI STOOL TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GI STOOL TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GI STOOL TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES GI STOOL TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES GI STOOL TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. GI STOOL TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. GI STOOL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GI STOOL TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GI STOOL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GI STOOL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GI STOOL TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GI STOOL TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GI STOOL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GI STOOL TESTING MARKET SIZE, BY BACTERIA TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GI STOOL TESTING MARKET SIZE, BY TRANSFERRIN ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GI STOOL TESTING MARKET SIZE, BY TUMOR M2-PK STOOL TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GI STOOL TESTING MARKET SIZE, BY GUAIAC FOB STOOL TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNO FOB AGGLUTINATION TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNO FOB ELISA TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GI STOOL TESTING MARKET SIZE, BY LATERAL FLOW IMMUNO FOB TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GI STOOL TESTING MARKET SIZE, BY OVA AND PARASITES TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GI STOOL TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GI STOOL TESTING MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES GI STOOL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 282. GI STOOL TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 283. GI STOOL TESTING MARKET, FPNV POSITIONING MATRIX, 2023